Literature DB >> 11083378

Recurrence of kernicterus in term and near-term infants in Denmark.

F Ebbesen1.   

Abstract

UNLABELLED: Classical acute bilirubin encephalopathy (kernicterus) in term and near-term infants had not been seen in Denmark for at least 20 y until 1994. From 1994 to 1998. however, six cases were diagnosed. Aetiology of the hyperbilirubinaemia was known in two infants; spherocytosis and galactosaemia, most likely known in two infants; possible A-O blood type immunization, and unknown in two infants. However, one of these last-mentioned infants had a gestational age of only 36 wk. The maximum plasma total bilirubin concentrations were 531-745 micromol/L. The increase in the number of cases of kernicterus was considered to have been caused by: (i) a decreased awareness of the pathological signs, (ii) a change in the assessment of the risk of bilirubin encephalopathy, (iii) early discharge of the infants from the maternity ward, (iv) so-called breastfeeding-associated jaundice, (v) demonstration of bilirubin being an antioxidant, and (vi) difficulty in estimating the degree of jaundice in certain groups of immigrants. Accordingly, for prevention: (a) Attempt to change the healthcare workers' understanding of the risk of bilirubin encephalopathy, (b) give further instructions, both orally and in writing, to mothers before discharge from the maternity ward, (c) be more liberal in giving infant formula supplements, (d) conduct home visits by the community nurse at an earlier stage, (e) follow authorized guidelines for phototherapy and exchange transfusion, (f) lower plasma bilirubin concentration limits as an indication for phototherapy and exchange transfusion, (g) screen all term and near-term infants, and (h) measure the skin's yellow colour with a device that corrects for the skin's melanin content.
CONCLUSIONS: Audit of the six cases presented indicates that measures are necessary in both the primary and secondary healthcare sectors if the risk of kemicterus is to be avoided. Screening may be considered, but in order to identify the problems it would first be reasonable to perform a larger prospective study in which audit is performed on all newborn infants, born at term and near-term, who develop a plasma bilirubin concentration above the exchange transfusion limit.

Entities:  

Mesh:

Year:  2000        PMID: 11083378     DOI: 10.1080/080352500750027592

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  23 in total

1.  The power of stories over statistics.

Authors:  Thomas B Newman
Journal:  BMJ       Date:  2003-12-20

Review 2.  American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus.

Authors:  D Manning
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

3.  Surveillance of severe neonatal hyperbilirubinemia: a view from south of the border.

Authors:  M Jeffrey Maisels; Thomas B Newman
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

Review 4.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Coombs' testing and neonatal hyperbilirubinemia.

Authors:  Michael Sgro; Douglas Campbell; Vibhuti Shah
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

6.  Family socio-demographic factors and maternal obstetric factors influencing appropriate health-care seeking behaviours for newborn jaundice in Sagamu, Nigeria.

Authors:  Tinuade A Ogunlesi; Funmilayo B Ogunlesi
Journal:  Matern Child Health J       Date:  2012-04

7.  Incidence and causes of severe neonatal hyperbilirubinemia in Canada.

Authors:  Michael Sgro; Douglas Campbell; Vibhuti Shah
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

8.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland.

Authors:  Donal Manning; Peter Todd; Melanie Maxwell; Mary Jane Platt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-30       Impact factor: 5.747

10.  Unbound Bilirubin and Auditory Neuropathy Spectrum Disorder in Late Preterm and Term Infants with Severe Jaundice.

Authors:  Sanjiv B Amin; Hongyue Wang; Nirupama Laroia; Mark Orlando
Journal:  J Pediatr       Date:  2016-03-04       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.